KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 83 filers reported holding KRONOS BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $25,016 | -36.5% | 20,174 | -33.4% | 0.00% | – |
| Q1 2024 | $39,378 | +68.6% | 30,291 | +123.1% | 0.00% | – |
| Q2 2023 | $23,354 | +36.8% | 13,578 | +16.1% | 0.00% | – |
| Q1 2023 | $17,069 | +19.7% | 11,691 | +32.8% | 0.00% | – |
| Q4 2022 | $14,262 | -86.3% | 8,804 | -71.5% | 0.00% | -100.0% |
| Q3 2022 | $104,000 | -13.3% | 30,905 | -6.2% | 0.00% | 0.0% |
| Q2 2022 | $120,000 | -72.6% | 32,947 | +2.2% | 0.00% | -75.0% |
| Q4 2021 | $438,000 | +131.7% | 32,230 | +307.7% | 0.00% | +100.0% |
| Q2 2021 | $189,000 | – | 7,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $3,428,989 | 3.75% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,609,469 | 0.39% |
| Acuitas Investments, LLC | 443,457 | $549,887 | 0.29% |
| CM Management, LLC | 135,000 | $167,400 | 0.15% |
| Privium Fund Management (UK) Ltd | 292,182 | $341,853 | 0.13% |
| Alphabet Inc. | 1,438,232 | $1,783,408 | 0.09% |
| Forefront Analytics, LLC | 134,998 | $167,400 | 0.08% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 1,665,797 | $2,044,488 | 0.04% |
| Artal Group S.A. | 842,954 | $1,045,263 | 0.03% |
| VESTIA PERSONAL WEALTH ADVISORS | 15,718 | $19,490 | 0.02% |